Results 221 to 230 of about 425,993 (391)

Emerging Trends in Patients Hospitalised With Cirrhosis—Aetiologies, Complications and Outcomes Compared to Other Chronic Health Conditions

Alimentary Pharmacology &Therapeutics, EarlyView.
Rates of inpatient mortality and complication rates in cirrhosis remain high. With regard to inpatient outcomes, cirrhosis is falling behind other chronic health conditions. ABSTRACT Background The aetiologies, complications and overall burden of cirrhosis have undergone changes in recent years.
Julian Pohl, Nirbaanjot Walia, Lukas Hofmann, Lena Wolters, Martin Schulz, Matthias Reinhardt, Brigitta Globke, Frank Tacke, Thomas Berg, Cornelius Engelmann   +9 more
wiley   +1 more source

Performance Evaluation of the Elecsys HCV Duo Immunoassay in the Public Healthcare Setting in Cape Town, South Africa. [PDF]

J Viral Hepat
Hardie DR, Korsman SNJ, Valley-Omar Z, Petersen N, Cable R, Spearman CW, Sonderup M.   +6 more
europepmc   +1 more source

Status of Health related Quality of life between HBV and HCV Patients of Pakistan [PDF]

The aim of the study is to explore the factors those differentiate health related quality of life (HRQOL) among hepatitis B (HBV) and hepatitis C (HCV) patients. Different public and private hospitals of Sargodha district were visited and 120 patients of
Ali, Mumtaz, Aslam, Muhammad Amir, Awan, Masood Sarwar, Waqas, Muhammad   +3 more
core   +1 more source

Research Communication: Serum Metabolomic Signatures Predict Tumour Recurrence After Resection or Ablation in Patients With Early‐Stage Hepatocellular Carcinoma

Alimentary Pharmacology &Therapeutics, EarlyView.
Serum metabolites may guide post‐treatment risk stratification for HCC recurrence. ABSTRACT Patients with hepatocellular carcinoma (HCC) often experience recurrence after curative therapies, underscoring a need for risk stratification models. We validated 6 and 13‐metabolite signatures in patients who achieved complete response following surgical ...
Ashwini Arvind, Hiroaki Kanzaki, Fouzia Ahmed, Naoto Fujiwara, Yujin Hoshida, Amit G. Singal   +5 more
wiley   +1 more source

High Efficiency and Safety of Hepatitis C Treatment Among People Who Inject Drugs in Vietnam. [PDF]

J Viral Hepat
Laureillard D, Binh NT, Vinh VH, Hong TT, Quillet C, Thanh NTT, Vallo R, Quynh BTN, Moles JP, Oanh KTH, Huong DT, Rapoud D, Feelemyer J, Michel L, Vickerman P, Fraser H, Weiss L, Lemoine M, Lacombe K, Jarlais DD, Khue PM, Nagot N.   +21 more
europepmc   +1 more source

Influence of hepatitis C virus (HCV) genotypes on HCV recombinant immunoblot assay patterns [PDF]

, 1995
Jean‐Michel Pawlotsky, F Roudot-Thoraval, C Pellet, Pascale Aumont, Françoise Darthuy, Jocelyne Rémiré, J Duval, Daniel Dhumeaux   +7 more
openalex   +1 more source

Glecaprevir and Pibrentasvir in Patients with HCV and Severe Renal Impairment

New England Journal of Medicine, 2017
E. Gane, E. Lawitz, D. Pugatch, G. Papatheodoridis, N. Bräu, A. Brown, S. Pol, V. Leroy, M. Persico, Christophe Moreno, M. Colombo, E. Yoshida, D. Nelson, Christine A. Collins, Y. Lei, M. Kosloski, F. Mensa   +16 more
semanticscholar   +1 more source

Prediction of Hepatocellular Carcinoma and Other Liver‐Related Events in Chronic Hepatitis B Patients With Metabolic Dysfunction or Metabolic Dysfunction‐Associated Steatotic Liver Disease

Alimentary Pharmacology &Therapeutics, EarlyView.
This study evaluated the performance of the PAGE‐B score in HCC risk among CHB patients with metabolic dysfunction or MASLD. The PAGE‐B score effectively stratified HCC risk in both MASLD and non‐MASLD patients, especially in those without cirrhosis, where low scores were linked to negligible 5‐year HCC risk. ABSTRACT Introduction Metabolic dysfunction
Lesley A. Patmore, Ivana Carey, Jordan J. Feld, Willem P. Brouwer, Keyur Patel, Maria Buti, Pieter Honkoop, Douwe F. Postma, Hans Blokzijl, Özgur. M. Koc, Eva van Oorschot, Kosh Agarwal, Marc van der Valk, Faydra I. Lieveld, Mai Kilany, Matthijs Kramer, Joep de Bruijne, Mark A. A. Claassen, Bettina E. Hansen, Robert A. de Man, Harry L. A. Janssen, R. Bart Takkenberg, Milan J. Sonneveld   +22 more
wiley   +1 more source

Evaluation of Blood Droplet Volumes on the Cobas Plasma Separation Card for HCV RNA Testing in Resource-Limited Settings. [PDF]

J Viral Hepat
Qureshi H, Canchola JA, Hai G, Latif AQ, Parkin NT, La Brot B.   +5 more
europepmc   +1 more source

Changes in HCV antibody levels after IFN therapy in patients with non-A, non-B chronic hepatitis.

, 1990
Satoru FUJIOKA, Kiyomi Yasuda, Kunihiko Hino, Yasumasa Nishiyama, T Kanno, Kouki KAKU, M Mine, Akinori FUKUHARA, Yukitaka Nashida, Toshiro Kondo, Hirohumi Niwa, Kiyohiko Kurai, Shiro Iino, Hiroshi Suzuki   +13 more
openalex   +2 more sources